Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H31NO3 |
Molecular Weight | 357.4864 |
Optical Activity | ( - ) |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CC#CCOC(=O)[C@@](O)(C1CCCCC1)C2=CC=CC=C2
InChI
InChIKey=XIQVNETUBQGFHX-QFIPXVFZSA-N
InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3/t22-/m0/s1
Molecular Formula | C22H31NO3 |
Molecular Weight | 357.4864 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Tolterodine: a review of its use in the treatment of overactive bladder. | 2001 |
|
Effect of OROS controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride. | 2001 Oct |
|
Augmentation ureterocystoplasty in bladder exstrophy: 5-year follow-up in two cases. | 2002 Dec |
|
[Urinary incontinence: anticholinergic treatment]. | 2004 Oct-Dec |
|
High performance liquid chromatographic determination of oxeladin citrate and oxybutynin hydrochloride and their degradation products. | 2005 Aug |
|
Prediction of genotoxicity of chemical compounds by statistical learning methods. | 2005 Jun |
|
Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices. | 2005 Mar 21 |
|
New transdermal bioadhesive film containing oxybutynin: In vitro permeation across rabbit ear skin. | 2006 Nov 15 |
|
Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin. | 2006 Oct |
|
Analysis of pharmacological effects of drugs used for treatment of urinary disturbance based on anticholinergic and smooth muscle-relaxing effects. | 2007 Jul |
|
Primary monosymptomatic nocturnal enuresis in children and adolescents. | 2007 Sep |
|
Generation of an agonistic binding site for blockers of the M(3) muscarinic acetylcholine receptor. | 2008 May 15 |
|
Locked-in Syndrome in a Nigerian male with Multiple Sclerosis: a case report and literature review. | 2008 Oct 30 |
|
Oxybutynin extended release for the management of overactive bladder: a clinical review. | 2009 Sep 21 |
|
Medical management of overactive bladder. | 2010 Apr |
|
Liquid Chromatographic Determination of Flavoxate HCl in Pharmaceutical Formulation. | 2010 Jul |
|
[Isolated primary nocturnal enuresis: international evidence based management. Consensus recommendations by French expert group]. | 2010 May |
|
Current practices in treatment of female genital fistula: a cross sectional study. | 2010 Nov 10 |
|
Urological manifestations of Chikungunya fever: A single centre experience. | 2010 Sep |
|
Dose escalation improves therapeutic outcome: post hoc analysis of data from a 12-week, multicentre, double-blind, parallel-group trial of trospium chloride in patients with urinary urge incontinence. | 2010 Sep 14 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:33:23 GMT 2023
by
admin
on
Sat Dec 16 19:33:23 GMT 2023
|
Record UNII |
5BRQ29UUB7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5BRQ29UUB7
Created by
admin on Sat Dec 16 19:33:24 GMT 2023 , Edited by admin on Sat Dec 16 19:33:24 GMT 2023
|
PRIMARY | |||
|
119618-21-2
Created by
admin on Sat Dec 16 19:33:24 GMT 2023 , Edited by admin on Sat Dec 16 19:33:24 GMT 2023
|
PRIMARY | |||
|
300000045599
Created by
admin on Sat Dec 16 19:33:24 GMT 2023 , Edited by admin on Sat Dec 16 19:33:24 GMT 2023
|
PRIMARY | |||
|
12152
Created by
admin on Sat Dec 16 19:33:24 GMT 2023 , Edited by admin on Sat Dec 16 19:33:24 GMT 2023
|
PRIMARY | |||
|
6098167
Created by
admin on Sat Dec 16 19:33:24 GMT 2023 , Edited by admin on Sat Dec 16 19:33:24 GMT 2023
|
PRIMARY | |||
|
C190351
Created by
admin on Sat Dec 16 19:33:24 GMT 2023 , Edited by admin on Sat Dec 16 19:33:24 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
RACEMATE -> ACTIVE ENANTIOMER |
|
||
|
TARGET -> INHIBITOR |
|
||
|
ENANTIOMER -> ENANTIOMER |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|